25th week of 2012 patent applcation highlights part 47 |
Patent application number | Title | Published |
20120156253 | Enzyme Treatment of Foodstuffs for Celiac Sprue - Administering an effective dose of glutenase to a Celiac or dermatitis herpetiformis patient reduces levels of toxic gluten oligopeptides, thereby attenuating or eliminating the damaging effects of gluten. | 2012-06-21 |
20120156254 | RECOMBINANT LAMININ-521 - The present disclosure related to isolated laminin-521, methods for making recombinant laminin-521, host cells that express recombinant laminin-521, and compositions containing laminin-521. Laminin-521 can maintain stem cells in vitro pluripotency, enable self-renewal, and enable single cell survival of human embryonic stem cells. When pluripotent human embryonic stem cells are cultured on plates coated with a matrix of recombinant laminin-521 (laminin 11), in the absence of differentiation inhibitors or feeder cells, the embryonic stem cells proliferate and maintain their pluripotency. It has also been discovered that human recombinant laminin-521 (laminin-11) provides single cell survival of stem cells after complete dissociation into a single cell suspension. Useful cell culture mediums containing at most 3.9 ng/ml of beta fibroblast growth factor (bFGF) are also described herein. | 2012-06-21 |
20120156255 | DRUG ELUTING PATCH FOR THE TREATMENT OF LOCALIZED TISSUE DISEASE OR DEFECT - A polymeric matrix for delivery of an HMG CoA reductase inhibitor such as a statin to tissue such as cardiac tissue in need thereof for the treatment or prevention of a disease or defect such as atrial fibrillation has been developed. In the preferred embodiment, a statin is delivered by means of a patch sutured to cardiac tissue at the time of cardiothoracic surgery. In the most preferred embodiment, the patch is a biodegradable material providing controlled or sustained release over a prolonged period of time, such as a week. Suitable materials include extracellular matrix, or other biodegradable hydrogels or polymeric materials providing sustained or controlled release of statin at the site of application. | 2012-06-21 |
20120156256 | NANOPARTICLES HAVING AT LEAST ONE ACTIVE INGREDIENT AND AT LEAST TWO POLYELECTROLYTES - The present invention relates to novel nanoparticles formed by at least one active ingredient and by at least two polyelectrolytes of opposite polarity, in particular characterized in that at least one of the two polyelectrolytes bears hydrophobic side groups and at least one of the two polyelectrolytes bears side groups of the polyalkylene glycol type, said nanoparticles having an average diameter ranging from 10 to 100 nm and comprising a quantity of groups of the polyalkylene glycol type such that the mass ratio w | 2012-06-21 |
20120156257 | METHOD FOR THE PREPARATION OF NANOPARTICLES - The present invention relates to a novel method for the preparation of nanoparticles with a diameter smaller than or equal to 500 nm, comprising bringing a solution (1) comprising nanoparticles of a first polyelectrolyte in the charged state, bearing hydrophobic side groups, together with (2) at least one second polyelectrolyte of opposite polarity to that of the first polyelectrolyte, characterized in that the ratio Z of the number of cationic groups relative to the number of anionic groups in the mixture of the two polyelectrolytes is comprised between 0.1 and 0.75 or between 1.3 and 2; and the total mass concentration C of polyelectrolytes is strictly less than 2 mg/g of the mixture. | 2012-06-21 |
20120156258 | Adjuvant or pharmaceutical preparation for transdermal or transmucosal administration - An adjuvant for transdermal or transmucosal administration which comprises at least one substance selected from an aliphatic alcohol, a free fatty acid and a fatty acid derivative but does not contain a substance represented by the following formula: wherein R | 2012-06-21 |
20120156259 | Biodegradable Polyethylene Glycol Based Water-Insoluble Hydrogels - The present invention relates to biodegradable polyethylene glycol based water-insoluble hydrogels comprising backbone moieties which are interconnected by hydrolytically degradable bonds, the backbone moieties further comprising reactive functional groups, wherein the water-insoluble hydrogel is further characterized in that the ratio between the time period for the complete degradation of the hydrogel by hydrolysis of the degradable bonds into water-soluble degradation products comprising one or more backbone moieties and the time period for the release of the first 10 mol-% of water-soluble degradation products comprising one or more backbone moieties based on the total amount of backbone moieties in the hydrogel is greater than 1 and equal to or less than 2. The invention further relates to conjugates of such hydrogels with ligands or ligating groups, prodrugs and pharmaceutical compositions as well as their use in a medicament. | 2012-06-21 |
20120156260 | Prodrugs Containing an Aromatic Amine Connected By an Amido Bond to a Linker - The present invention relates to a prodrug or a pharmaceutically acceptable salt thereof comprising a drug linker conjugate D-L, wherein an aromatic amine containing biologically active moiety is connected (bound) by an amido bound to a linker. The invention also relates to pharmaceutical compositions comprising said prodrugs and their use as medicaments. | 2012-06-21 |
20120156261 | DISINTEGRATING PARTICLE COMPOSITION AND ORALLY RAPIDLY DISINTEGRATING TABLET - There has been a need for an orally rapidly disintegrating tablet which has a good texture and taste in the oral cavity, such a sufficient hardness as not giving any worry of being chipped or dusted during production or transportation and good disintegrating properties in the oral cavity and can sustain a sufficient hardness even under humid conditions after opening. Disclosed are a disintegrating particle composition which is prepared by dispersing, in the presence of water, mannitol, xylitol, an inorganic excipient, a disintegrating agent and carmellose and drying, and an orally rapidly disintegrating tablet which comprises said disintegrating particle composition, an active substance and a disintegrating agent. The disintegrating tablet has a good texture and taste, an appropriate hardness and good disintegrating properties and can sustain a sufficient hardness under humid conditions. | 2012-06-21 |
20120156262 | N-(CYANOPHENYL)PYRAZOLECARBOXAMIDE AQUEOUS FORMULATION - Disclosed is an insecticidal suspension concentrate composition comprising by weight based on the total weight of the composition: (a) from about 0.3 to about 30% of 3-bromo-1-(3-chloro-2-pyridinyl)-N-[4-cyano-2-methyl-6-[(methylamino)carbonyl]phenyl]-1H-pyrazole-5-carboxamide; (b) from about 5 to about 70% of a nonionic ethylene oxide-propylene oxide block copolymer component having a water solubility of at least about 5% by weight at 20° C., a hydrophilic-lipophilic balance value ranging from about 5 to about 18 and an average molecular weight ranging from about 900 to about 20000 daltons; and (c) from about 20 to about 95% of water. Also disclosed is a method for controlling an insect pest comprising diluting said suspension concentrate composition with water to form a diluted composition, and contacting the insect pest or its environment with an insecticidally effective amount of said diluted composition. | 2012-06-21 |
20120156263 | Ursodeoxycholic Acid-Synthetic Hydrotalcite-Eudragit Hybrid, Pharmaceutical Composition Containing the Same and Method for Preparing the Same - The present invention relates to an ursodeoxycholic acid-synthetic hydrotalcite-Eudragit hybrid, a pharmaceutical composition containing the same and a method for preparing the same. The ursodeoxycholic acid-synthetic hydrotalcite-Eudragit hybrid according to the present invention is very useful as an active ingredient of a pharmaceutical composition because of its bitter-taste-blocking effect and improved body absorption rate with high solubility. | 2012-06-21 |
20120156264 | INJECTABLE DEPOT FORMULATION COMPRISING CRYSTALS OF ILOPERIDONE - An injectable depot formulation comprising crystals having structure (I) wherein R is (FII) and the X50 value of the crystals is from 1 to 200 microns. Depot formulations containing crystals of iloperidone or its metabolites have the following advantages: (i) release of the crystals in plasma can be correlated with the size of the crystals; (ii) absorption of the crystals in plasma can be correlated with the size of the crystals; (iii) the particle size of the crystals can be controlled by crystal engineering and/or milling; and (iv) the crystals are stable upon storage, and stable to sterilization procedures, such as gamma irradiation. | 2012-06-21 |
20120156265 | CONFORMABLE TISSUE REPAIR IMPLANT CAPABLE OF INJECTION DELIVERY - A conformable tissue implant is provided for use in repairing or augmenting a tissue defect or injury site. The tissue implant contains a tissue carrier matrix comprising a plurality of biocompatible, bioresorbable granules and at least one tissue fragment in association with the granules. The tissue fragment contains one or more viable cells that can migrate from the tissue and populate the tissue carrier matrix. Also provided is a method for injectably delivering the tissue implant. | 2012-06-21 |
20120156266 | COMPOSITIONS COMPRISING LILIUM CANDIDUM EXTRACTS AND USES THEREOF - Provided are compositions comprising certain extracts of | 2012-06-21 |
20120156267 | COMPOSITIONS COMPRISING LILIUM MARTAGON EXTRACTS AND USES THEREOF - Provided are compositions comprising an extract of | 2012-06-21 |
20120156268 | COSMETIC COMPOSITIONS AND METHODS FOR ENHANCED UV PROTECTION - The present disclosure relates generally to cosmetic formulations having enhanced UV protection factors. The present disclosure relates particularly, but not by way of limitation, to UV-protecting cosmetic formulations comprising cosmetic powders and having low loadings of organic sunscreens. | 2012-06-21 |
20120156269 | COSMETIC COMPOSITION COMPRISING ENCAPSULATED SILICONE COMPOUNDS - The invention relates to a cosmetic composition comprising, in a physiologically acceptable medium, at least one organopolysiloxane compound X having at least two alkenyl unsaturated groups, at least one organohydrogensiloxane compound Y and at least one hydrosilylation catalyst, and said compounds X and Y reacting together via a hydrosilylation reaction in the presence of the catalyst, at least one compound among the compounds X and Y being present in said composition in a form encapsulated in silica shell microcapsules, said catalyst being associated with said encapsulated compound X and/or Y or being encapsulated separately, the microcapsules being in suspension in an aqueous phase. Application for the cosmetic care and/or making up of keratin materials. | 2012-06-21 |
20120156270 | METHOD FOR SMOOTHING OUT THE SKIN BY FILLING IN RECESSED PORTIONS - The invention relates to a method for smoothing out the skin by filling in recessed portions of the skin, said method comprising: i) filling the recessed portions by means of a filling-in product which has, when it is applied in said recessed portions, an elastic modulus of greater than 20 000 Pascals at 25° C. for a stress frequency of 1 Hertz, a flow point of greater than 500 Pascals, and, for applied stresses of less than the yield stress, a viscosity of greater than 100 000 Pa.s, and ii) applying, to the recessed portions thus filled in, a film or a composition capable of forming a film | 2012-06-21 |
20120156271 | COMPOSITION FOR COSMETICS, COSMETIC, METHOD FOR PRODUCING OIL-IN-WATER EMULSION COSMETIC, AND TWO SEPARATE LAYER-TYPE COSMETIC - The present invention relates to a composition for cosmetics including a polyglycerol fatty acid ester, which is an ester of polyglycerol having an average degree of polymerization of 4 to 100 with a fatty acid having 2 to 18 carbon atoms, has a hydroxyl value equal to or less than 15 mgKOH/g, and has a specific gravity at 20° C. of 0.96 to 1.15; a cosmetic which includes the composition for cosmetics; a method for producing an oil-in-water emulsion cosmetic which includes mixing the composition for cosmetics with a hydrophilic solvent and emulsifying; and a two-separate-layer-type cosmetic, which comprises the composition for cosmetics with water, packaged in a transparent or translucent container. The present invention relates to the composition for cosmetics which can be appropriately used in producing a cosmetic giving a highly excellent feel in using and having a very good texture, a cosmetic showing a very high stability over time as an emulsion even though having a low viscosity, and a two-separate-layer-type cosmetic which can be easily dispersed uniformly by lightly shaking before using and, after using, easily separated into the original two layers, including an oily layer and an aqueous layer, and remain stable. | 2012-06-21 |
20120156272 | COMPOSITION FOR COSMETIC, PHARMACEUTICAL OR DIETARY APPLICATIONS - The invention is related to a composition comprising vegetable extract, carbohydrate and phospholipid for cosmetic, pharmaceutical or dietary application. | 2012-06-21 |
20120156273 | COMPOSITION COMPRISING INSECTICIDE-WAX PARTICLES - The present invention relates to compositions for pest control, more particularly insecticides, to a process for preparing them, and to the use of such formulations for sustained control of animal pests (arthropods) on various surfaces. The present invention further relates to active ingredient-wax particles in which at least one active insecticidal ingredient is dispersed in wax. | 2012-06-21 |
20120156274 | INFECTION-RESISTANT POLYURETHANE FOAMS, METHOD FOR PRODUCING THE SAME AND USE THEREOF IN ANTISEPTIC WOUND DRESSING - The present invention describes microbicidal hydrophilic polyurethane foams endowed with polyhexamethylenebiguanide (PHMB) and/or its hydrochloride and also a superabsorbent, wound contact materials obtainable therefrom and processes for producing the therapeutically endowed polyurethane foams and the wound contact materials obtainable therefrom. | 2012-06-21 |
20120156275 | Process for coating an active ingredient with a urea-formaldehyde polymer - The present invention relates to novel urea-formaldehyde polymers coated with an active ingredient, a method of making the same, and their use. | 2012-06-21 |
20120156276 | Connective tissue stimulating peptides - Novel peptides are described which comprise an amino acid motif selected from the group consisting of “PG”, “GP”, “PI” and “IG” and having up to 10 amino acids upstream and/or downstream of the amino acid motif, wherein “P” in the motif is proline or hydroxyproline and the peptide stimulates the development, maintenance and repair of bone, cartilage and associated connective tissue. The invention further relates to pharmaceutical compositions of these peptides, as well as therapeutic and prophylactic uses of such peptides. | 2012-06-21 |
20120156278 | SYSTEMS AND METHODS FOR PREPARING AUTOLOGOUS FIBRIN GLUE - A method of regenerating tissue in a living organism. The method includes the act of contacting an affected area of the living organism with a solid-fibrin web, the solid-fibrin web comprising platelets that release growth factors about one minute after contact to regenerate the tissue in the living organism. | 2012-06-21 |
20120156279 | HIGH PENETRATION PRODRUG COMPOSITIONS OF PEPTIDES AND PEPTIDE-RELATED COMPOUNDS - The invention provides compositions of novel high penetration compositions (HPC) or high penetration prodrugs (HPP) of peptides and peptide-related compounds, which are capable of crossing biological barriers with higher penetration efficiency comparing to their parent drugs. The HPPs are capable of being converted to parent drugs or drug metabolites after crossing the biological barrier and thus can render treatments for the conditions that the parent drugs or metabolites can. Additionally, the HPPs/HPCs are capable of reaching areas that parent drugs may not be able to access or to render a sufficient concentration at the target areas and therefore render novel treatments. The HPPs/HPCs can be administered to a subject through various administration routes, e.g., locally delivered to an action site of a condition with a high concentration or systematically administered to a biological subject and enter the general circulation with a faster rate. | 2012-06-21 |
20120156280 | MYELOID DERIVED SUPPRESSOR CELL INHIBITING AGENTS - Myeloid derived suppressor cell (MDSC) inhibitory agents and vaccine and/or adjuvant enhancers are provided. Improved vaccine treatment regimens employing these agents are also provided. Cancer vaccines and methods for inhibiting tumor growth and cancer metastases are also presented. The myeloid derived suppressor cell (MDSC) inhibiting agents are described as bisphosphonates (such as liposomal clodronate) and CCR2 inhibitors and/or CCR2 antagonists. Methods for enhancing antibody titer levels in response to an antigen of interest are also provided. | 2012-06-21 |
20120156281 | Meningococcal Vaccine Based on Lipooligosaccharide (LOS) and Neisseria Meningitidis Protein - The invention relates to a vaccine against | 2012-06-21 |
20120156282 | EXPANDING THE T CELL REPERTOIRE TO INCLUDE SUBDOMINANT EPITOPES BY VACCINATION WITH ANTIGENS DELIVERED AS PROTEIN FRAGMENTS OR PEPTIDE COCKTAILS - A convenient way of inducing a broad recognition of dominant and subdominant responses to epitopes of any given antigen of importance for prophylaxis or treatment of a chronic disease is provided. The method involves immunizing with pools of overlapping fragments (synthetic peptides, e.g., 10-30 mers with 2-20 aa overlap) of the desired antigen in appropriate adjuvants. The T cell repertoire is primed to include not only the immunodominant epitope recognized when the intact molecule is used for immunization and induced by the chronic infection itself, but induce a much broader and balanced response to a number of the subdominant epitopes as well. The vaccination with peptide mix induces a T-cell response that includes response to subdominant epitopes is important for protection against chronic disease that on their own induces a response focused only on immunodominant epitopes. | 2012-06-21 |
20120156283 | Methods and Compositions for Wound Treatment - The present disclosure relates to methods for identifying proteins or peptide motifs of intracellular, extracellular, or extracellular matrix proteins specifically exposed in wound sites, as well as compositions for treating wounds, and methods for their use. | 2012-06-21 |
20120156284 | ENHANCED BIOLOGICAL AUTOLOGOUS TISSUE ADHESIVE COMPOSITION AND METHODS OF PREPARATION AND USE - The invention includes a composition useful for preparing a tissue sealant for use on a patient, comprising: autologous fibrinogen, an activating agent and at least one supplement. The invention includes a method of treating a disc having at least one defect, comprising: introducing a composition into the disc, wherein the composition comprises autologous fibrinogen and an activating agent, and wherein the composition forms fibrin. | 2012-06-21 |
20120156285 | METHODS OF TREATING HYPERTRIGLYCERIDEMIA - In various embodiments, the present invention provides methods of treating and/or preventing cardiovascular-related disease and, in particular, a method of blood lipid therapy comprising administering to a subject in need thereof a pharmaceutical composition comprising eicosapentaenoic acid or a derivative thereof | 2012-06-21 |
20120156286 | COMPOSITIONS AND METHODS FOR INCREASED DELIVERY OF COENZYME Q10 - Disclosed are compositions comprising Coenzyme Q10 and a cetylated fatty acid blend, pharmaceutical formulations comprising the same and methods of increasing the systemic concentration of Coenzyme Q10 in an individual, comprising administering the same to the individual. | 2012-06-21 |
20120156287 | Use of Vitelline Protein B as a Microencapsulating Additive - The present invention includes compositions and methods for the use of an encapsulation additive having between about 0.1 to about 30 percent isolated and purified vitelline protein B to provide for mixed and extended release formulations. | 2012-06-21 |
20120156288 | MICROCAPSULES CONTAINING SALTS FOR FOOD PRODUCTS - A composition for delivering edible salts into food products via microcapsules having a protein-polysaccharide shell matrix and an edible salt-containing active material. A method of treating osteoporosis is also disclosed. | 2012-06-21 |
20120156289 | Biodegradable Osmotic Pump Implant For Drug Delivery - The present disclosure relates to a drug delivery device including a biodegradable housing and a hydrogel within the biodegradable housing. The housing, the hydrogel, or both, may include a bioactive agent. Also disclosed is a method of drug delivery including the steps of forming the biodegradable housing, in embodiments a hydrogel, suspending a bioactive agent in the hydrogel, and introducing a second hydrogel and/or precursors of a second hydrogel into the biodegradable housing. | 2012-06-21 |
20120156290 | PROCESS FOR PREPARING OXYMORPHONE, NALTREXONE, AND BUPRENORPHINE - Methods are provided which include converting oripavine to other opiates, including converting oripavine to naltrexone, buprenorphine, 14-hydroxymorphinone and/or converting 14-hydroxymorphinone to oxymorphone. Purification and salt formation are optionally included. | 2012-06-21 |
20120156291 | STABLE COMPOSITIONS OF FAMOTIDINE AND IBUPROFEN - Stable pharmaceutical compositions of famotidine and ibuprofen in a single unit dosage form are disclosed herein. The compositions comprise a famotidine core having a reduced or minimal surface area surrounded by a layer of ibuprofen. In some embodiments, the ibuprofen is in direct physical contact with the famotidine. | 2012-06-21 |
20120156292 | STABLE COMPOSITIONS OF FAMOTIDINE AND IBUPROFEN - Stable pharmaceutical compositions of famotidine and ibuprofen in a single unit dosage form are disclosed herein. The compositions comprise a famotidine core having a reduced or minimal surface area surrounded by a layer of ibuprofen. In some embodiments, the ibuprofen is in direct physical contact with the famotidine. | 2012-06-21 |
20120156293 | ANTACID AND LAXATIVE TABLET - A tablet having excellent disintegration properties, as a tableted product, for a long time and has excellent shape-retention stability by the improvement of the strength of the tablet. The antacid and laxative tablet comprises magnesium oxide particles as the main component, wherein (a) the average secondary particle diameter measured by a laser diffraction scattering method of the magnesium oxide particles is 0.5 to 10 μm, (b) the content of the magnesium oxide particles is 85 to 96 wt %, (c) the content of crystalline cellulose as a binder is 2 to 8 wt %, (d) the content of croscarmellose sodium as a disintegrating agent-I is 0.8 to 2.5 wt %, (e) the content of insoluble polyvinyl pyrrolidone as a disintegrating agent-II is 1 to 3.5 wt %, and (f) the content of a lubricant is 0.5 to 2 wt %. | 2012-06-21 |
20120156294 | Pharmaceutical Compositions of Selective Factor Xa Inhibitors for Oral Administration - The present invention provides pharmaceutical compositions for oral administration comprising a therapeutically effective amount of a selective factor Xa inhibitor or a pharmaceutically acceptable salt thereof and an enhancer, wherein the enhancer is a medium chain fatty acid or a salt, ester, ether, or derivative of a medium chain fatty acid and has a carbon chain length of from 4 to 20 carbon atoms. The present invention also provides a method for obtaining a reproducible bioavailability of selective factor Xa inhibitor in a subject after oral administration comprising orally administering a pharmaceutical composition as described above. | 2012-06-21 |
20120156295 | ANTIBIOTIC COMPOUNDS - Purified compounds of formula I are described. Compounds include all stereoisomeric forms and all tautomeric forms of the compounds of formula I and pharmaceutically acceptable salts and derivatives. Processes for the production of the antibacterial compounds by fermentation of the microorganism belonging to | 2012-06-21 |
20120156296 | ANTIOXIDANTS IN FISH OIL POWDER AND TABLETS - This invention relates to antioxidants and combinations of antioxidants used to prevent oxidation of pharmaceutical and nutraceutical products in the form of powders, granulates, tablets, emulsions, gels and the like comprising one or more fatty acids and/or fatty acid derivatives and, optionally, at least one carbohydrate carrier alone or together with vitamins, minerals and/or pharmaceuticals. In particular, the invention concerns the use of antioxidants to reduce oxidation of powders, tablets, gels and emulsions comprising high concentrations and high doses of omega-3 fatty acids or derivatives thereof. | 2012-06-21 |
20120156297 | COMPOSITIONS COMPRISING LILIUM CANDIDUM EXTRACTS AND USES THEREOF - Provided are compositions comprising certain extracts of | 2012-06-21 |
20120156298 | COMPOSITIONS COMPRISING LILIUM SIBERIA EXTRACTS AND USES THEREOF - Provided are compositions comprising an extract of | 2012-06-21 |
20120156299 | COMPOSITIONS COMPRISING LILIUM MARTAGON EXTRACTS AND USES THEREOF - Provided are compositions comprising an extract of | 2012-06-21 |
20120156300 | MICROBUBBLES AND METHODS FOR OXYGEN DELIVERY - Compositions containing a carrier and microbubbles encapsulating one or more gases, preferably oxygen, and methods for making and using the compositions are described herein. The microbubbles contain a lipid envelope. The compositions may be administered to a patient to quickly deliver large amounts of oxygen to the patient's blood supply or directly to a tissue in need of oxygen. The compositions may be administered via injection or as a continuous infusion. The compositions contain a concentrated microbubble suspension, where the suspension contains at least 40 mL oxygen/dL suspension. The microbubbles are preferably less than 20 microns in diameter, more preferably less than 15 microns in diameter. The microbubbles described herein may be administered to a patient in an effective amount to increase in oxygen concentration in the patient's blood, and/or one or more tissues or organs. | 2012-06-21 |
20120156301 | Methods and Compositions for Treating and Preventing Symptoms of Hormonal Variations - The present invention relates to methods, compositions, and kits for treating or preventing symptoms of hormonal variation. The method comprises the steps of administering an effective amount of Dextromethorphan or Dextrorphan, or a pharmaceutically acceptable salt thereof, to a subject having one or more symptoms of hormonal variations. | 2012-06-21 |
20120156302 | BIODEGRADABLE PARTICLE AND METHOD FOR PRODUCING THE SAME - The present invention aims to provide a biodegradable particle capable of being molded without an aggregation or cohesion of the particles, capable of being carried or injected without clogging by an aggregation in a micro diameter tube such as of a catheter, needle or syringe mainly used in pharmaceutical and medical applications of which inner diameter is smaller than the particle size or in a blood vessel and capable of being smoothly degraded in a specified period of time so that degraded component can finally be absorbed or discharged in vitro. As means for solving the problem, the present invention provides a biodegradable particle characterized in that a compressive modulus of the particle in water saturated state is 10 MPa or less. | 2012-06-21 |
20120156303 | MICROCAPSULE AND PRODUCTION METHOD THEREOF - A microcapsule in which a liquid droplet is coated with a resin, wherein in the droplet, a pesticidally active solid ingredient is suspended in a compound of formula (I), wherein R represents a C1-C5 alkyl group, is useful as a formulation of a pesticidally active solid ingredient. | 2012-06-21 |
20120156304 | BRANCHED POLYOL POLYESTERS, BLENDS, AND PHARMACEUTICAL FORMULATIONS COMPRISING SAME - Disclosed herein are branched polyol polyesters, which are useful in pharmaceutical formulations. Also disclosed are blends, microparticles, and other formulations, comprising the branched polyol polyesters. | 2012-06-21 |
20120156305 | METHODS FOR ENHANCING GENOME STABILITY AND TELOMERE ELONGATION IN EMBRYONIC STEM CELLS - The disclosure provides methods for increasing genome stability of an embryonic stem (ES) cell or induced pluripotent stem (iPS) cell, increasing telomere length in an ES or iPS cell, or both, for example by contacting an ES or iPS cell with an agent that increases expression of Zscan4 in the cell. Methods for increasing the genome stability in a population of ES or iPS cells, increasing telomere length in a population of ES or iPS cells, or both, are provided, for example by selecting Zscan4 | 2012-06-21 |
20120156306 | VIRAL INACTIVATED PLATELET EXTRACT, USE AND PREPARATION THEREOF - The invention relates to a viral-safe platelet extract, to its preparation and use. The extract comprises a mixture of biologically active platelet derived factors. | 2012-06-21 |
20120156307 | MEDICAL USES OF NANOCLUSTERED WATER - The present invention relates to methods of treating or preventing an infection or infectious disease in a mammal, or sanitizing mammalian tissue, or treating or preventing psoriasis in a mammal, comprising topically administering to said mammal an electrolytic acid water comprising free chlorine, wherein: a) from 90% to 99.9% of said free chlorine is present in the form of hypochlorous acid; b) said water has a pH of from 0.5 to 5.0; and c) said water has oxidation reduction potential (ORP) of greater than 1100 mV. The present invention also relates to methods of healing, repair or regeneration of a tissue in a mammal comprising topically administering to said tissue said electrolytic acid water. | 2012-06-21 |
20120156308 | MINERAL TRIOXIDE AGGREGATE (MTA) COMPOSITION AND USE - The present application discloses a fast-setting mineral trioxide aggregate (MTA) with fluoride release for practical treatment of diseases in teeth and bone, e.g. for caries treatment and/or prevention. The cariostatic MTA contain calcia-silica-alumina cement with moderately increased tricalcium aluminate content allowing high calcium hydroxide release. The MTA composition support remineralization and biomineralization, and it is suitable for stimulation of hard tissue regeneration. MTA embodiments contain superplasticizerand nanosilicate for improved mechanical properties. The MTA compositions include optional radiocontrast and nano-enriched leachable fluorine, nitrate, strontium, and phosphate. The fast-setting MTA paste exhibits flow-to-clay-like consistency, which allows new practical applications including cavity lining, temporary restoration, bonding, and cementations in one MTA embodiment. The high calcium hydroxide and high fluoride release are suitable for caries prevention and treatment, and per se inhibition of dental symptoms. | 2012-06-21 |
20120156309 | Using Aqueous Oxygenation to Improve Animal Health & Wellness - Dispersing gas in a liquid provides a mixture of saturated, supersaturated or hypersaturated solution to provide a suspension of bubbles containing gas therein into which animal tissue is immersed for health or wellness treatment. A two-phase mixture is provided with dissolved gas as a suspension of microbubbles. Methods for making, maintaining, and using the two-phase mixture are provided. Gas molecules may be introduced into a liquid at high velocity under elevated pressure to form a supersaturated solution that retains the gas, preferably oxygen, in solution when exposed to ambient conditions. | 2012-06-21 |
20120156310 | METHOD FOR PREDICTION OF THERAPEUTIC EFFECT OF CHEMOTHERAPY EMPLOYING EXPRESSION LEVEL OF DIHYDROPYRIMIDINE DEHYDROGENASE GENE AS MEASURE - The present invention provides an antitumor agent comprising cisplatin and a combination drug of tegafur/gimeracil/oteracil potassium that ensures an excellent life-prolongation effect in advanced gastric cancer patients that is superior to that of the standard therapy in Europe and the U.S. using an agent that contains 5-FU and does not contain a dihydropyrimidine dehydrogenase inhibitor, by way of selecting the patients based on dihydropyrimidine dehydrogenase. | 2012-06-21 |
20120156311 | COMBINATION THERAPY FOR CANCER COMPRISING A PLATINUM-BASED ANTINEOPLASTIC AGENT AND A BIOCOMPATIBLE ELECTRON DONOR - The combination of a biocompatible electron donor and a platinum-based antineoplastic agent exhibits improved efficacy in treating cancer This improved activity appears to be the result of electron transfer from the aforementioned donor compound to the platinum-based antineoplastic agent As the electron donor alone has no chemotherapeutic utility in treating cancer, the resulting combinations appear to be synergistic in nature In select preferred embodiments, the biocompatible electron donor is an amine (such as N,N,N′,N′-tetramethyl-p-phenylene diamine or indocyanine green), a phenolic compound (such as a flavanol or catechin), or a quinone (such as an aromatic quinone), while the antineoplastic is cisplatin. | 2012-06-21 |
20120156312 | Compositions for Inhibiting Growth of Cancer Stem Cells - The present invention is a biomarker of chemotherapeutic drug-resistant cancer stem cells and a method of inhibiting the growth of drug-resistant cancer stem cells. In one embodiment the cancer stem cells are testicular cancer germ cells. In another embodiment the present invention is a method of overcoming drug resistance in cancer treatment where the combination of low dose decitabine and administration of a chemotherapeutic drug to which cancer cells were resistant results in successful cancer treatment. | 2012-06-21 |
20120156313 | CORROSION INHIBITION OF HYPOCHLORITE SOLUTIONS USING SUGAR ACIDS AND Ca - Corrosion inhibitor compositions and methods of use are disclosed. Sugar acids and calcium corrosion inhibitors combined with hypochlorite sources provide use solutions for effective corrosion inhibition for metal surfaces. | 2012-06-21 |
20120156314 | 11 beta, 13-DIHYDROHELENALIN DERIVATIVES AND USES THEREOF AS BOMBESIN RECEPTOR SUBTYPE 3 AGNOISTS - The present invention relates to compounds of formual (I): | 2012-06-21 |
20120156315 | Composition for Treating Vitiligo or Canities Comprising Extract from Sophora Japonica as Active Ingredient - Disclosed is a composition for treating or preventing vitiligo or canities comprising | 2012-06-21 |
20120156316 | BIOCOMPATIBLE TEA TREE OIL COMPOSITIONS - There are disclosed non-phytotoxic biocompatible compositions comprising tea tree oil (TTO), as well as their use and methods for their production. Other embodiments are also disclosed. | 2012-06-21 |
20120156317 | CENTER MECHANISM OF TIRE VULCANIZER - In a center mechanism of a tire vulcanizer of the present invention, in order to improve working efficiency and lower total height, after a green tire is vulcanized and patterned and becomes a vulcanized tire, a bladder well is lifted from a bottom position where a lower bead ring is positioned on a lower mold and a bladder is installed in the green tire to a top position where the lower bead ring is positioned above the lower mold and an upper clamp, and the upper clamp, a lower clamp, and the bladder are placed in the bladder well, while heights of the upper clamp and the lower clamp are fixed. | 2012-06-21 |
20120156318 | Flat finisher spring coupler and maintenance method - A select spring coupler structure is outfitted upon a flat finisher assembly or apparatus so as to enhance the user's ability to maintain the flat finisher apparatus. The flat finisher apparatus essentially comprises at least one (tension) coil spring removably held in tension between opposing anchor structures. The select spring coupler structure according to the present invention is outfittable upon the coil spring at the first spring end of the coil spring. The spring coupler structure comprises certain radially extending structure for engaging the first spring end and certain finger engaging structure for enabling manual alteration (i.e. via one's digits) of spring tension so as to disengage the first spring end from respective anchoring structure. The spring coupler structure may be twisted into engagement with the first spring end(s) via the helical structure of adjacent loops of the coil spring to couple therewith. | 2012-06-21 |
20120156319 | DEVICE FOR MANUFACTURING A THREE-DIMENSIONAL OBJECT - A device for the production of a three-dimensional object made of solidifiable material has at least one processing unit for processing of the solidifiable material into a fluid phase in order to discharge the material from a material reservoir via a discharge unit in the direction of a construction space in the form of discrete drops. The closing mechanism has an elastic deformable solid body joint. | 2012-06-21 |
20120156320 | MANUFACTURING-PROCESS EQUIPMENT - A manufacturing-process equipment has a platform assembly, a measurement feedback assembly and a laser-working assembly. The platform assembly has a base and a hybrid-moving platform. The base has a mounting frame. The hybrid-moving platform is mounted on the base and has a long-stroke moving stage and a piezo-driven micro-stage. The long-stroke moving stage has a benchmark set and a driving device. The piezo-driven micro-stage is connected to the long-stroke moving stage and has a working platform. The measurement feedback assembly is securely mounted on the platform assembly and has a laser interferometer, a reflecting device and a signal-receiving device. The laser-working assembly is mounted on the platform assembly, is electrically connected to the measurement feedback assembly and has a laser direct-writing head, a controlling interface device and a positioning interface device. | 2012-06-21 |
20120156321 | WIDE AREA STAMP FOR ANTIREFLECTIVE SURFACE - Nanoimprint molds for molding a surface of a material are provided. A nanoimprint mold includes a body with a molding surface that is formed by shaped nanopillars. The nanopillars may be formed on a substrate and shaped by performing at least a first partial oxidation of the nanopillars and then removing at least a portion of the oxidized material. Once shaped, a hard substance is deposited on the nanopillars to begin forming the molding surface of the nanoimprint mold. The deposition of a hard substance is followed by the deposition of carbon nanotube on the hard substance and then the removal of the substrate and nanopillars from the molding surface. | 2012-06-21 |
20120156322 | Apparatus for Injection Molding - An adaptor bushing for an injection molding apparatus comprising a manifold, a nozzle assembly and a nozzle retention device, comprises: (i) a bushing passage for fluid communication between a passage of the manifold and a nozzle passage; (ii) at least one transition region joining portions of the bushing passage; and, (iii) at least one alignment surface effective to (a) align longitudinal centerlines of the bushing passage, manifold passage and nozzle passage and (b) eliminate or reduce relative tilt of the adaptor bushing, nozzle assembly and manifold so that with the adaptor bushing clamped between the manifold and nozzle assembly, leakage of material at the interfaces of the bushing passage with the manifold passage and nozzle passage is eliminated or reduced to an acceptable level under normal operating conditions. A manifold and nozzle assembly construction comprises an adaptor bushing interposed between a manifold passage and a nozzle passage. | 2012-06-21 |
20120156323 | Hot-Runner System Including Melt-Flow Control Structure Integrally Formed with the Manifold Body - A hot-runner system is provided with a manifold body including a manifold melt channel, and a melt-flow control structure communicating with the manifold melt channel. The melt-flow control structure is integrally formed with the manifold body. | 2012-06-21 |
20120156324 | Mold-Tool System having Melt Splitting Device Including Uninterrupted Melt Channels Extending from Inlet and Outlets - A mold-tool system is provided which includes a melt distribution device and a melt splitting device configured to interact with the melt distribution device. The melt splitting device includes a single inlet and multiple outlets spaced from the single inlet. The outlets are configured for fluid communication with the melt distribution device. The melt splitting device further includes a plurality of uninterrupted melt channels, where each melt channel extends from the inlet to an associated one of the outlets. | 2012-06-21 |
20120156325 | Multiple-Gate Injection Molding Apparatus - One or more nozzles define separate nozzle channels. The nozzles are coupled to a manifold, so that each of the nozzle channels communicates with a different mold gate. A molding material distribution insert is coupled to the manifold and has a body defining a distribution channel and a plurality of drop channels equal in number to the nozzle channels. The distribution channel is an open distribution channel formed on an outer surface of the body and enclosed by the manifold. The drop channels intersect the distribution channel and exit the body at a different one of the nozzle channels. A valve pin bushing can extend into the drop channels. Valve pins can extend from actuators, through the valve pin bushing and the drop channels, and to the mold gates. A valve pin holder can be coupled to the actuator and coupled to heads of the valve pins. | 2012-06-21 |
20120156326 | METHOD FOR EXTENDING MOLD-FREE SHELF LIFE AND IMPROVING FLAVOR CHARACTERISTICS OF BAKED GOODS - The present invention provides a novel method for extending mold-free shelf life and for improving the flavor of baked goods by applying live yeast on the surface of the baked good after baking and cooling before packaging the baked good in closed bags and storing the packaged baked goods at ambient temperature. This method can be used for all kinds of baked goods including breads, rolls, bagels, pizza crusts, wheat flour tortillas, croissants, cakes, muffins, donuts and pita breads. This method can also be used to produce baked goods containing live probiotic yeast ( | 2012-06-21 |
20120156327 | PROCESS FOR MANUFACTURING OF A FERMENTED DAIRY PRODUCT - The present invention relates to a process for manufacturing fermented dairy products, in particular stirred milk products. The invention concerns a process for the manufacture of a fermented dairy product without any cooling step for stopping fermentation due to the use of a weakly post-acidifying lactic bacterium culture as a starter. | 2012-06-21 |
20120156328 | METHODS FOR PREPARING CAKES USING PHOSPHOLIPASES AND CAKE BATTER AND CAKE MIX COMPOSITIONS COMPRISING PHOSPHOLIPASES - The present invention relates to methods for preparing a cake using phospholipase variants and cake and cake mix compositions comprising same. | 2012-06-21 |
20120156329 | Expression Of Granular Starch Hydrolyzing Enzymes In Trichoderma And Process For Producing Glucose From Granular Starch Substrates - The present invention relates to filamentous fungal host cells and particularly | 2012-06-21 |
20120156330 | LOW SODIUM MARGARINE SPREAD ENRICHED WITH PROBIOTICS FIELD - Described herein are shelf stable low sodium compositions having reduced levels of trans fats. The compositions comprise a reduced trans base oil, an unhydrogenated oil, water, a low sodium sea salt, a probiotic and one or more additives. Also provided are methods of preparing such compositions and use thereof. | 2012-06-21 |
20120156331 | CHEESE-LIKE FOOD COMPOSITION AND A METHOD FOR PRODUCING THE SAME - An object of the present invention is to provide a cheese-like food composition having physical properties and texture analogous to those of soft cheese and comprising a plant protein as a protein ingredient. The present inventors have discovered that the above object can be achieved by a food composition having cheese-like texture, which comprises a soy protein in an amount ranging from 0.5% to 10% by mass as a solid content and a wheat protein in an amount ranging from 15% to 35% by mass as a solid content with respect to the total amount of the food composition, wherein the soy protein is coagulated. | 2012-06-21 |
20120156332 | Protecting bioactive food ingredients using microorganisms having reduced metabolizing capacity - The invention concerns a food product containing living microorganisms and bioactive food ingredients of interest, wherein the living microorganisms and the bioactive food ingredients of interest are organized so as to reduce metabolizing of said bioactive ingredients by said living microorganisms. More particularly, the invention concerns the use therefor of living microorganisms having reduced capacity for metabolizing the bioactive ingredients. | 2012-06-21 |
20120156333 | STABILIZED BETA CRYPTOXANTHIN-CONTAINING WATER AND THE USE THEREOF - A stabilized β cryptoxanthin-containing water being capable of being utilized in food and drink is provided with low cost. The stabilized β cryptoxanthin-containing water of the present embodiments is a stabilized β cryptoxanthin-containing water containing: water; β cryptoxanthin; and vitamin C, wherein the β cryptoxanthin is stabilized by adding the vitamin C to the water containing the β cryptoxanthin. The vitamin C has superior safety and is inexpensive, and the β cryptoxanthin can be stabilized by the vitamin C alone without using in combination with the other stabilizing agent. Therefore, according to the present embodiments, the β cryptoxanthin in the water can be stabilized with safety and low cost. | 2012-06-21 |
20120156334 | SINGLE-USE BARREL FOR STORING AND RACKING A PRESSURIZED BEVERAGE SUCH AS BEER OR LEMONADE - The barrel includes a bag, a container and a lid that are equipped with rigid mating elements with sealing; a cap that includes a body that supports elements for closing and elements for drafting-off; a part that forms the neck, structurally separate from the lid; the outside lateral surface of the part that forms the neck and the inside lateral surface of the orifice of the lid are equipped with rigid mating elements with sealing; the bag is mated to the part that forms the neck toward its inside end; at least one hole on the container and/or the lid makes it possible to inject a positively pressurized gas inside the barrel and outside of the bag so as to compress the bag; airtight sealing elements are able to seal or open the hole, and when they seal the hole, to maintain the positive pressure that prevails inside the barrel. | 2012-06-21 |
20120156335 | CAN BOTTLES IN A BOTTOMED, CYLINDRICAL CONFIGURATION, AND CAN PRODUCTS FILLED UP THEREIN WITH A SOFT OR HARD DRINK - A can bottle in a bottomed, cylindrical configuration, which is constructed of a metal material has a cylindrical side wall and a bottom joined to and integrated with the side wall. The said bottom includes domed portions that flex and extend downwardly and outwardly, and flexed support legs formed by extending a plurality of peripheral edge sites of the domed portions arranged at uniform angles further downwardly and outwardly in a flexed fashion. The bottom satisfies a condition: 1.04≦R | 2012-06-21 |
20120156336 | BEVERAGE PREPARATION MACHINES - A beverage preparation machine of the type which uses pre-packaged containers of beverage ingredients comprises a cartridge recognition device for determining the type of beverage to be prepared from a cartridge inserted into the machine and a variable geometry valve located downstream of a cartridge when inserted in the machine. The valve enables preparation of beverages at a range of pressures by having at least an open position and at least one restricted flow position, and a controller for selecting an initial valve position and controlling the subsequent operation of the valve according to the determination of the type of beverage to be prepared by the cartridge recognition device. | 2012-06-21 |
20120156337 | Apparatus and Method for Brewed and Espresso Drink Generation - An apparatus that generates brewed beverages by performing one or more chemical and/or mechanical processes may receive requests to produce specified brewed beverages. The apparatus may include a master controller that initiates and controls performance of the chemical and/or mechanical processes to produce the specified beverages. The master controller may adaptively apply one or more process accelerators during the performance of one of the chemical or mechanical processes to accelerate the process or to achieve a desired qualitative or quantitative characteristic for a beverage or a component thereof. The adaptive application of one or more process accelerators may be dependent on a multiple-variable process profile developed for the process and/or a specified beverage. For example, the pressure in a steam wand and/or the depth of the wand may be varied during a process to froth milk in order to produce frothed milk having a desired temperature. | 2012-06-21 |
20120156338 | VARIABLY THROTTLED BEVERAGE AERATOR - A method and apparati for regulating introduction of ambient air begins with initiating a liquid flow through a venturi to induce a localized drop in pressure at a bowl situated at a venturi throat. Airflow is admitted at a barrel inlet, through a first barrel lumen segment to a first half-moon port at a throttle first side. The airflow is selectively obstructed by a second half-moon port whose rotational position relative to the first half-moon port defines a variable aperture. The airflow is conducted from the second half-moon port through a second barrel lumen segment to the barrel outlet and mixing with the liquid to produce an aerated liquid. | 2012-06-21 |
20120156339 | Apparatus and Method for Brewed and Espresso Drink Generation - An apparatus that generates brewed beverages by performing one or more chemical and/or mechanical processes may receive requests to produce specified brewed beverages. The apparatus may include a master controller that initiates and controls performance of the chemical and/or mechanical processes to produce the specified beverages. The master controller may adaptively apply one or more process accelerators during the performance of one of the chemical or mechanical processes to accelerate the process or to achieve a desired qualitative or quantitative characteristic for a beverage or a component thereof. The adaptive application of one or more process accelerators may be dependent on a multiple-variable process profile developed for the process and/or a specified beverage. For example, the pressure in a steam wand and/or the depth of the wand may be varied during a process to froth milk in order to produce frothed milk having a desired temperature. | 2012-06-21 |
20120156340 | Plasma Generation of CO for Modified Atmosphere Packaging - A CO-containing modified atmosphere packaging (MAP) gas is generated from a processing gas including CO | 2012-06-21 |
20120156341 | Plasma Generation of CO for Modified Atmosphere Packaging - A CO-containing modified atmosphere packaging (MAP) gas is generated from a processing gas including CO | 2012-06-21 |
20120156342 | Method of accelerated water vapor removal from high sugar concentrates - A process of, and apparatus for, accelerated water vapor removal from molasses is provided. Raw molasses is preheated; continuously agitated while advancing at a flowrate of at least about 1.5 gpm through a cooking apparatus in the presence of a temperature greater than 310° F.; continuously agitated while advancing through a cooling apparatus at a reduced temperature, and while removing separated water vapor water from the cooked molasses to form a cooled molasses having a homogenous temperature profile. The molasses may be admixed with supplements. The product is then packaged. An orificed helical conveyor having a plurality of protrusions from the outer perimeter agitates the cooking molasses. An orificed helical conveyor having gaps in the perimeter of the conveyor alternating with protrusions along the perimeter of the conveyor agitates the cooling molasses. | 2012-06-21 |
20120156343 | System and Method for Managing the Generation of Brewed Beverages Using Shared Resources - A system that generates brewed beverages may receive requests to produce specified brewed beverages. The system may include a scheduler that initiates and controls the performance of one or more chemical or mechanical processes to produce the beverages. While one chemical or mechanical process for producing a beverage is being performed, other processes may be performed for production of the beverage or another beverage. The scheduler may determine the time at which to perform each process, the time at which a beverage should be presented, the resources to be used to perform the processes, or the time at which to perform a cleaning process, dependent on an actual or expected demand for beverages, or dependent on a target time for beverage retrieval. Shared resources may be applied to the production of beverages for high priority orders, while partially completed beverages for lower priority orders are staged for subsequent advancement. | 2012-06-21 |
20120156344 | System and Method for Managing the Generation of Brewed Beverages Using Shared Resources - A system that generates brewed beverages may receive requests to produce specified brewed beverages. The system may include a scheduler that initiates and controls the performance of one or more chemical or mechanical processes to produce the beverages. While one chemical or mechanical process for producing a beverage is being performed, other processes may be performed for production of the beverage or another beverage. The scheduler may determine the time at which to perform each process, the time at which a beverage should be presented, the resources to be used to perform the processes, or the time at which to perform a cleaning process, dependent on an actual or expected demand for beverages, or dependent on a target time for beverage retrieval. Shared resources may be applied to the production of beverages for high priority orders, while partially completed beverages for lower priority orders are staged for subsequent advancement. | 2012-06-21 |
20120156345 | BOTTLE TOP AERATOR - A method and apparati to exploit a bottle mounted housing, defining a liquid passageway for a liquid flow from the bottle. A funnel coaxially situated to the liquid flow and extending from a funnel inlet converging in a downstream direction at a funnel outlet joins a bowl coaxially situated to the liquid flow and converging in the downstream direction at a bowl outlet. A horn extends from the bowl outlet and flares downstream to a horn outlet having a greater cross-sectional area than that of the bowl outlet. At least one barrel has a barrel lumen extending from a barrel inlet to a barrel outlet at an acute angle to the liquid flow to admit an airflow through the lumen and into the bowl. A resilient sealing gasket including at least one annular flange, is removable engaged with an opening in a bottle for pouring liquid from the bottle. | 2012-06-21 |
20120156346 | Apparatus for Manufacture of Flat Bread and Method for Manufacture the Same - A device and method for heating a food product are disclosed. The device contains a support member for supporting a food product in a first position and a second position, a heating mechanism associated with the support member and positioned to heat the support member when the support member is in the first position and in the second position, and another heating mechanism positioned to heat the food product when the food product is in the second position. | 2012-06-21 |
20120156347 | Cookie Shaping Device - A cookie folding device for folding food to a desired shape. One embodiment of the cookie folding device includes a base, a center ridge and two arms. The arms pivot downwards, causing a cookie to bend around the arms and over the center ridge. | 2012-06-21 |
20120156348 | DEVICE AND METHOD FOR THERMALLY PROCESSING FOOD PRODUCTS - Device and method for thermally processing food products, comprising a receptacle which is intended to receive food products, a thermal processing bath downstream of the receptacle, the receptacle having a cross-section in the form of a chute, a supply of thermal processing water with the food products being moved into the receptacle by the water, and a sluice arranged downstream of the receptacle, the sluice having at least one open position which allows the thermal processing water and the food products moved by the thermal processing water to pass, and a closed position which retains the food products in thermal processing water, the thermal processing bath comprising a thermal processing water vessel which is arranged downstream of the sluice, and a member for timing the duration of the thermal processing operation, the timing member being provided with vanes, the sluice being synchronised with the timing member in the closed position when a vane is opposite the sluice and in an open position when the access to the thermal processing water vessel is free. | 2012-06-21 |
20120156349 | Grill - A grill configured to cook food placed above it. The grill comprising a base having an interior and containing a support for the food being cooked and gas jets for burning gas and generating heat to cook the food. The gas jets are directed downwards towards the interior of the base, thereby heating a bed of heat absorbent inert material. This material is heated by the gas jets and then radiates heat upwardly in the direction towards the support. | 2012-06-21 |
20120156350 | COOKING VESSEL - The invention provides an improved cooking vessel design that can be used to easily employ a combustible fuel to produce reliably cooked and acceptable food products, especially poultry and chicken products. | 2012-06-21 |
20120156351 | TASTE IMPROVER FOR HIGH INTENSITY SWEETENER - A taste improver which is capable of effectively suppressing unpleasant bitter taste, harsh taste, and astringent taste peculiar to high intensity sweeteners without changing original flavor and taste of food and of reproducing taste intensity and a flavor profile by using the high intensity sweeteners, which are equal to those attained by using sugars such as sucrose. | 2012-06-21 |
20120156352 | Quick-Cook Grains and Pulses - A method for making a quick-cook grain or pulse via flat plate compression or gun puffing by controlling the porosity of the grain or pulse. Further, the grain or pulse made in accordance with this invention retains the texture, flavor and appearance of the original grain or pulse. | 2012-06-21 |
20120156353 | LIQUID FORMULATION CONTAINING PROTEIN AND LAMBDA CARRAGEENAN FROM HALYMENIALES - A liquid formulation comprising protein and lambda carrageenan, wherein the lambda carrageenan comprises lambda carrageenan from at least one seaweed of the taxonomic order Halymeniales. | 2012-06-21 |